Madam Speaker, Canada has among the highest patented medicine prices in the world and these high prices negatively affect the ability of patients to access new medicines.
In August 2019, we announced the final amendments to the patented medicine regulations. This is the first substantive update to the regulations in more than 20 years and the member knows that new guidelines were just released about a week ago. These amendments will give the Patented Medicine Prices Review Board new tools to protect Canadians from excessive prices of patented medicines.